Home > Balance Sheet > VENUS REMEDIES

VENUS REMEDIES
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Contingent Liabilities ₹20 Cr₹38 Cr₹30 Cr₹40 Cr₹11 Cr

What is the latest Contingent Liabilities ratio of VENUS REMEDIES ?

The latest Contingent Liabilities ratio of VENUS REMEDIES is ₹20 Cr based on Mar2026 Consolidated results.
Year Contingent Liabilities
Mar2026₹20 Cr
Mar2025₹38 Cr
Mar2024₹30 Cr
Mar2023₹40 Cr
Mar2022₹11 Cr

How is Contingent Liabilities of VENUS REMEDIES Trending?

Years Contingent Liabilities % Change
Mar2026 ₹20 Cr
-48.00
Mar2025 ₹38 Cr
25.48
Mar2024 ₹30 Cr
-23.13
Mar2023 ₹40 Cr
272.42
Mar2022 ₹11 Cr -

Compare Contingent Liabilities of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹2,073.7 Cr -3% -9.2% 197.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


VENUS REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-3%

-9.2%

197.9%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses